Structure

Physi-Chem Properties

Molecular Weight:  398.32
Volume:  450.993
LogP:  5.93
LogD:  4.511
LogS:  -4.734
# Rotatable Bonds:  4
TPSA:  37.3
# H-Bond Aceptor:  2
# H-Bond Donor:  1
# Rings:  4
# Heavy Atoms:  2

MedChem Properties

QED Drug-Likeness Score:  0.55
Synthetic Accessibility Score:  4.495
Fsp3:  0.815
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.562
MDCK Permeability:  1.1447083124949131e-05
Pgp-inhibitor:  0.959
Pgp-substrate:  0.878
Human Intestinal Absorption (HIA):  0.004
20% Bioavailability (F20%):  0.997
30% Bioavailability (F30%):  0.927

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.743
Plasma Protein Binding (PPB):  95.25609588623047%
Volume Distribution (VD):  1.049
Pgp-substrate:  2.095768928527832%

ADMET: Metabolism

CYP1A2-inhibitor:  0.161
CYP1A2-substrate:  0.256
CYP2C19-inhibitor:  0.15
CYP2C19-substrate:  0.843
CYP2C9-inhibitor:  0.335
CYP2C9-substrate:  0.079
CYP2D6-inhibitor:  0.059
CYP2D6-substrate:  0.595
CYP3A4-inhibitor:  0.813
CYP3A4-substrate:  0.456

ADMET: Excretion

Clearance (CL):  17.465
Half-life (T1/2):  0.084

ADMET: Toxicity

hERG Blockers:  0.432
Human Hepatotoxicity (H-HT):  0.409
Drug-inuced Liver Injury (DILI):  0.437
AMES Toxicity:  0.008
Rat Oral Acute Toxicity:  0.732
Maximum Recommended Daily Dose:  0.878
Skin Sensitization:  0.92
Carcinogencity:  0.907
Eye Corrosion:  0.041
Eye Irritation:  0.05
Respiratory Toxicity:  0.977

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC33913

Natural Product ID:  NPC33913
Common Name*:   VMXMLOFNEQBYHM-INVHITAPSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  VMXMLOFNEQBYHM-INVHITAPSA-N
Standard InCHI:  InChI=1S/C27H42O2/c1-17(2)25(29)11-6-18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h6-7,11,17-18,20-24,28H,8-10,12-16H2,1-5H3/b11-6+/t18-,20+,21+,22-,23+,24+,26+,27-/m1/s1
SMILES:  CC(C)C(=O)/C=C/[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3356400
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0003566] Cholestane steroids
          • [CHEMONTID:0001469] Cholesterols and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. PMID[23548547]
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. PMID[25497963]
NPO22674 Caulerpa racemosa Species Caulerpaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1210 Individual Protein T-cell protein-tyrosine phosphatase Homo sapiens Inhibition < 50.0 % PMID[486891]
NPT178 Individual Protein Protein-tyrosine phosphatase 1B Homo sapiens IC50 = 49970.0 nM PMID[486891]
NPT205 Individual Protein Protein-tyrosine phosphatase 1C Homo sapiens Inhibition < 50.0 % PMID[486891]
NPT206 Individual Protein Protein-tyrosine phosphatase 2C Homo sapiens Inhibition < 50.0 % PMID[486891]
NPT1870 Individual Protein Receptor-type tyrosine-protein phosphatase F (LAR) Homo sapiens Inhibition < 50.0 % PMID[486891]
NPT519 Cell Line SH-SY5Y Homo sapiens Activity = 15.98 % PMID[486891]
NPT81 Cell Line A549 Homo sapiens IC50 > 100000.0 nM PMID[486891]
NPT911 Individual Protein Dual specificity phosphatase Cdc25B Homo sapiens Inhibition < 50.0 % PMID[486891]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 > 100000.0 nM PMID[486891]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC33913 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9747 High Similarity NPC472265
0.939 High Similarity NPC58063
0.9268 High Similarity NPC474733
0.9268 High Similarity NPC145879
0.9268 High Similarity NPC474732
0.9268 High Similarity NPC474778
0.9268 High Similarity NPC31564
0.9157 High Similarity NPC475740
0.9125 High Similarity NPC6434
0.9036 High Similarity NPC118648
0.9036 High Similarity NPC222613
0.9036 High Similarity NPC475022
0.9024 High Similarity NPC59453
0.9024 High Similarity NPC214043
0.9024 High Similarity NPC85774
0.9024 High Similarity NPC221758
0.8974 High Similarity NPC113733
0.8974 High Similarity NPC321381
0.8974 High Similarity NPC107059
0.8974 High Similarity NPC321016
0.8953 High Similarity NPC272746
0.8941 High Similarity NPC26959
0.8941 High Similarity NPC186688
0.8941 High Similarity NPC146554
0.8941 High Similarity NPC1015
0.8941 High Similarity NPC268406
0.8941 High Similarity NPC31985
0.8929 High Similarity NPC93778
0.8916 High Similarity NPC22133
0.8916 High Similarity NPC469948
0.8861 High Similarity NPC318495
0.8861 High Similarity NPC155986
0.8861 High Similarity NPC198968
0.8851 High Similarity NPC474736
0.8846 High Similarity NPC288035
0.8846 High Similarity NPC304309
0.8846 High Similarity NPC28657
0.8846 High Similarity NPC162742
0.8846 High Similarity NPC136188
0.8846 High Similarity NPC230301
0.8846 High Similarity NPC22105
0.8846 High Similarity NPC285893
0.8846 High Similarity NPC134847
0.8837 High Similarity NPC48010
0.8824 High Similarity NPC471722
0.881 High Similarity NPC51014
0.8795 High Similarity NPC473246
0.878 High Similarity NPC151519
0.8765 High Similarity NPC241290
0.8765 High Similarity NPC209944
0.8765 High Similarity NPC234193
0.8765 High Similarity NPC164840
0.875 High Similarity NPC18603
0.875 High Similarity NPC307965
0.875 High Similarity NPC76931
0.875 High Similarity NPC474216
0.875 High Similarity NPC477522
0.875 High Similarity NPC87604
0.875 High Similarity NPC473943
0.8736 High Similarity NPC475806
0.8734 High Similarity NPC300324
0.8734 High Similarity NPC240604
0.8734 High Similarity NPC134330
0.8734 High Similarity NPC129165
0.8721 High Similarity NPC119416
0.8721 High Similarity NPC472240
0.8721 High Similarity NPC473999
0.8721 High Similarity NPC309603
0.8721 High Similarity NPC262858
0.8706 High Similarity NPC475772
0.8706 High Similarity NPC89747
0.869 High Similarity NPC470574
0.8667 High Similarity NPC108078
0.8659 High Similarity NPC47761
0.8659 High Similarity NPC264245
0.8642 High Similarity NPC47982
0.8642 High Similarity NPC143182
0.8642 High Similarity NPC84694
0.8642 High Similarity NPC81306
0.8642 High Similarity NPC109546
0.8642 High Similarity NPC328714
0.8642 High Similarity NPC28862
0.8625 High Similarity NPC34019
0.8621 High Similarity NPC85173
0.8621 High Similarity NPC126993
0.8621 High Similarity NPC191684
0.8608 High Similarity NPC141071
0.8608 High Similarity NPC257347
0.8608 High Similarity NPC471723
0.8605 High Similarity NPC328313
0.8605 High Similarity NPC328539
0.859 High Similarity NPC471799
0.8588 High Similarity NPC155011
0.8588 High Similarity NPC72133
0.8571 High Similarity NPC237712
0.8571 High Similarity NPC321187
0.8571 High Similarity NPC329043
0.8571 High Similarity NPC82902
0.8571 High Similarity NPC161423
0.8571 High Similarity NPC227064
0.8571 High Similarity NPC58841
0.8554 High Similarity NPC50964
0.8554 High Similarity NPC49964
0.8539 High Similarity NPC196485
0.8539 High Similarity NPC245972
0.8539 High Similarity NPC8993
0.8537 High Similarity NPC472478
0.8537 High Similarity NPC2482
0.8537 High Similarity NPC26117
0.8523 High Similarity NPC131872
0.8523 High Similarity NPC473998
0.8519 High Similarity NPC275910
0.8506 High Similarity NPC32830
0.8506 High Similarity NPC76879
0.8506 High Similarity NPC474245
0.8506 High Similarity NPC86319
0.8506 High Similarity NPC275740
0.8506 High Similarity NPC477943
0.85 High Similarity NPC96319
0.85 High Similarity NPC470362
0.85 High Similarity NPC189883
0.8488 Intermediate Similarity NPC141292
0.8488 Intermediate Similarity NPC136548
0.8481 Intermediate Similarity NPC471797
0.8471 Intermediate Similarity NPC29447
0.8471 Intermediate Similarity NPC471224
0.8471 Intermediate Similarity NPC474218
0.8452 Intermediate Similarity NPC476082
0.8452 Intermediate Similarity NPC278648
0.8434 Intermediate Similarity NPC209620
0.8434 Intermediate Similarity NPC82986
0.8434 Intermediate Similarity NPC23852
0.8434 Intermediate Similarity NPC474759
0.8434 Intermediate Similarity NPC474531
0.8434 Intermediate Similarity NPC470383
0.8434 Intermediate Similarity NPC474683
0.8434 Intermediate Similarity NPC474752
0.8434 Intermediate Similarity NPC7505
0.8434 Intermediate Similarity NPC474731
0.8427 Intermediate Similarity NPC475255
0.8427 Intermediate Similarity NPC470923
0.8427 Intermediate Similarity NPC134826
0.8427 Intermediate Similarity NPC12722
0.8427 Intermediate Similarity NPC474807
0.8427 Intermediate Similarity NPC109305
0.8427 Intermediate Similarity NPC250575
0.8415 Intermediate Similarity NPC1319
0.8415 Intermediate Similarity NPC30986
0.8415 Intermediate Similarity NPC209430
0.8395 Intermediate Similarity NPC214570
0.8391 Intermediate Similarity NPC143767
0.8391 Intermediate Similarity NPC53911
0.8391 Intermediate Similarity NPC474677
0.8391 Intermediate Similarity NPC292491
0.8391 Intermediate Similarity NPC471724
0.8391 Intermediate Similarity NPC131470
0.8391 Intermediate Similarity NPC310752
0.8372 Intermediate Similarity NPC94666
0.8372 Intermediate Similarity NPC327115
0.8372 Intermediate Similarity NPC20688
0.8372 Intermediate Similarity NPC469994
0.8372 Intermediate Similarity NPC474970
0.837 Intermediate Similarity NPC103051
0.837 Intermediate Similarity NPC114274
0.8354 Intermediate Similarity NPC474140
0.8353 Intermediate Similarity NPC205845
0.8333 Intermediate Similarity NPC189972
0.8333 Intermediate Similarity NPC470614
0.8333 Intermediate Similarity NPC279410
0.8333 Intermediate Similarity NPC101462
0.8333 Intermediate Similarity NPC1272
0.8333 Intermediate Similarity NPC476186
0.8333 Intermediate Similarity NPC5985
0.8333 Intermediate Similarity NPC111015
0.8333 Intermediate Similarity NPC119562
0.8315 Intermediate Similarity NPC185936
0.8315 Intermediate Similarity NPC110923
0.8315 Intermediate Similarity NPC74296
0.8315 Intermediate Similarity NPC212948
0.8315 Intermediate Similarity NPC168027
0.8313 Intermediate Similarity NPC236112
0.8295 Intermediate Similarity NPC2983
0.8295 Intermediate Similarity NPC177141
0.8293 Intermediate Similarity NPC167037
0.8293 Intermediate Similarity NPC244385
0.8293 Intermediate Similarity NPC285761
0.8293 Intermediate Similarity NPC82635
0.8293 Intermediate Similarity NPC477514
0.8293 Intermediate Similarity NPC6978
0.8293 Intermediate Similarity NPC138621
0.8276 Intermediate Similarity NPC474684
0.8276 Intermediate Similarity NPC317590
0.8276 Intermediate Similarity NPC90652
0.8276 Intermediate Similarity NPC142361
0.8272 Intermediate Similarity NPC237460
0.8272 Intermediate Similarity NPC202642
0.8272 Intermediate Similarity NPC247325
0.8272 Intermediate Similarity NPC244488
0.8272 Intermediate Similarity NPC73875
0.8272 Intermediate Similarity NPC46160

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC33913 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9024 High Similarity NPD4786 Approved
0.8953 High Similarity NPD6079 Approved
0.8846 High Similarity NPD6942 Approved
0.8846 High Similarity NPD7339 Approved
0.878 High Similarity NPD3667 Approved
0.8721 High Similarity NPD5328 Approved
0.8642 High Similarity NPD4195 Approved
0.8588 High Similarity NPD3618 Phase 1
0.8571 High Similarity NPD3666 Approved
0.8571 High Similarity NPD3665 Phase 1
0.8571 High Similarity NPD3133 Approved
0.85 High Similarity NPD3701 Clinical (unspecified phase)
0.8352 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.8352 Intermediate Similarity NPD5221 Approved
0.8352 Intermediate Similarity NPD5222 Approved
0.8261 Intermediate Similarity NPD5173 Approved
0.8222 Intermediate Similarity NPD4202 Approved
0.8161 Intermediate Similarity NPD5279 Phase 3
0.8118 Intermediate Similarity NPD4221 Approved
0.8118 Intermediate Similarity NPD4223 Phase 3
0.8095 Intermediate Similarity NPD7525 Registered
0.809 Intermediate Similarity NPD4753 Phase 2
0.8085 Intermediate Similarity NPD5286 Approved
0.8085 Intermediate Similarity NPD4696 Approved
0.8085 Intermediate Similarity NPD5285 Approved
0.8046 Intermediate Similarity NPD5329 Approved
0.8043 Intermediate Similarity NPD5210 Approved
0.8043 Intermediate Similarity NPD4629 Approved
0.8025 Intermediate Similarity NPD6924 Approved
0.8025 Intermediate Similarity NPD4784 Approved
0.8025 Intermediate Similarity NPD6926 Approved
0.8025 Intermediate Similarity NPD4785 Approved
0.8022 Intermediate Similarity NPD6399 Phase 3
0.8 Intermediate Similarity NPD7152 Approved
0.8 Intermediate Similarity NPD7150 Approved
0.8 Intermediate Similarity NPD5223 Approved
0.8 Intermediate Similarity NPD7151 Approved
0.7957 Intermediate Similarity NPD4697 Phase 3
0.7955 Intermediate Similarity NPD5690 Phase 2
0.7931 Intermediate Similarity NPD4197 Approved
0.7931 Intermediate Similarity NPD3668 Phase 3
0.7917 Intermediate Similarity NPD5224 Approved
0.7917 Intermediate Similarity NPD5226 Approved
0.7917 Intermediate Similarity NPD5225 Approved
0.7917 Intermediate Similarity NPD4633 Approved
0.7917 Intermediate Similarity NPD5211 Phase 2
0.7875 Intermediate Similarity NPD7144 Approved
0.7875 Intermediate Similarity NPD7143 Approved
0.7872 Intermediate Similarity NPD4755 Approved
0.7835 Intermediate Similarity NPD5175 Approved
0.7835 Intermediate Similarity NPD5174 Approved
0.7831 Intermediate Similarity NPD6933 Approved
0.7816 Intermediate Similarity NPD4788 Approved
0.7789 Intermediate Similarity NPD5290 Discontinued
0.7778 Intermediate Similarity NPD4243 Approved
0.7755 Intermediate Similarity NPD5141 Approved
0.7753 Intermediate Similarity NPD4690 Approved
0.7753 Intermediate Similarity NPD7146 Approved
0.7753 Intermediate Similarity NPD5205 Approved
0.7753 Intermediate Similarity NPD5330 Approved
0.7753 Intermediate Similarity NPD7334 Approved
0.7753 Intermediate Similarity NPD4138 Approved
0.7753 Intermediate Similarity NPD4689 Approved
0.7753 Intermediate Similarity NPD4693 Phase 3
0.7753 Intermediate Similarity NPD4688 Approved
0.7753 Intermediate Similarity NPD6409 Approved
0.7753 Intermediate Similarity NPD6684 Approved
0.7753 Intermediate Similarity NPD7521 Approved
0.775 Intermediate Similarity NPD6923 Approved
0.775 Intermediate Similarity NPD6922 Approved
0.7717 Intermediate Similarity NPD7515 Phase 2
0.7708 Intermediate Similarity NPD4700 Approved
0.77 Intermediate Similarity NPD6881 Approved
0.77 Intermediate Similarity NPD6899 Approved
0.7684 Intermediate Similarity NPD6084 Phase 2
0.7684 Intermediate Similarity NPD6083 Phase 2
0.7674 Intermediate Similarity NPD4695 Discontinued
0.7667 Intermediate Similarity NPD4751 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3617 Approved
0.76 Intermediate Similarity NPD5697 Approved
0.7582 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7582 Intermediate Similarity NPD6672 Approved
0.7582 Intermediate Similarity NPD5737 Approved
0.7582 Intermediate Similarity NPD6903 Approved
0.7558 Intermediate Similarity NPD7645 Phase 2
0.7558 Intermediate Similarity NPD6929 Approved
0.7556 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7556 Intermediate Similarity NPD5280 Approved
0.7556 Intermediate Similarity NPD4694 Approved
0.7549 Intermediate Similarity NPD7290 Approved
0.7549 Intermediate Similarity NPD6883 Approved
0.7549 Intermediate Similarity NPD7102 Approved
0.7529 Intermediate Similarity NPD6932 Approved
0.7525 Intermediate Similarity NPD4730 Approved
0.7525 Intermediate Similarity NPD6011 Approved
0.7525 Intermediate Similarity NPD5168 Approved
0.7525 Intermediate Similarity NPD4729 Approved
0.75 Intermediate Similarity NPD5739 Approved
0.75 Intermediate Similarity NPD7128 Approved
0.75 Intermediate Similarity NPD6675 Approved
0.75 Intermediate Similarity NPD6402 Approved
0.7476 Intermediate Similarity NPD6650 Approved
0.7476 Intermediate Similarity NPD6617 Approved
0.7476 Intermediate Similarity NPD6869 Approved
0.7476 Intermediate Similarity NPD6649 Approved
0.7476 Intermediate Similarity NPD6847 Approved
0.7476 Intermediate Similarity NPD8130 Phase 1
0.7475 Intermediate Similarity NPD4754 Approved
0.7471 Intermediate Similarity NPD6930 Phase 2
0.7471 Intermediate Similarity NPD6931 Approved
0.7471 Intermediate Similarity NPD4748 Discontinued
0.7451 Intermediate Similarity NPD6012 Approved
0.7451 Intermediate Similarity NPD6013 Approved
0.7451 Intermediate Similarity NPD6014 Approved
0.7444 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7145 Approved
0.7439 Intermediate Similarity NPD4691 Approved
0.7439 Intermediate Similarity NPD4747 Approved
0.7423 Intermediate Similarity NPD7638 Approved
0.7404 Intermediate Similarity NPD8297 Approved
0.7404 Intermediate Similarity NPD6882 Approved
0.7381 Intermediate Similarity NPD4058 Approved
0.7379 Intermediate Similarity NPD5251 Approved
0.7379 Intermediate Similarity NPD5247 Approved
0.7379 Intermediate Similarity NPD5249 Phase 3
0.7379 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD5248 Approved
0.7379 Intermediate Similarity NPD5135 Approved
0.7379 Intermediate Similarity NPD5169 Approved
0.7379 Intermediate Similarity NPD5250 Approved
0.7379 Intermediate Similarity NPD4634 Approved
0.7368 Intermediate Similarity NPD7748 Approved
0.7363 Intermediate Similarity NPD4623 Approved
0.7363 Intermediate Similarity NPD4519 Discontinued
0.7353 Intermediate Similarity NPD5128 Approved
0.7353 Intermediate Similarity NPD7320 Approved
0.7347 Intermediate Similarity NPD7640 Approved
0.7347 Intermediate Similarity NPD7639 Approved
0.734 Intermediate Similarity NPD5284 Approved
0.734 Intermediate Similarity NPD5281 Approved
0.7327 Intermediate Similarity NPD4768 Approved
0.7327 Intermediate Similarity NPD4767 Approved
0.7326 Intermediate Similarity NPD5776 Phase 2
0.7326 Intermediate Similarity NPD6925 Approved
0.7317 Intermediate Similarity NPD4137 Phase 3
0.7308 Intermediate Similarity NPD5216 Approved
0.7308 Intermediate Similarity NPD5215 Approved
0.7308 Intermediate Similarity NPD5217 Approved
0.7308 Intermediate Similarity NPD5127 Approved
0.7294 Intermediate Similarity NPD4190 Phase 3
0.7294 Intermediate Similarity NPD5275 Approved
0.7292 Intermediate Similarity NPD5695 Phase 3
0.729 Intermediate Similarity NPD7115 Discovery
0.7282 Intermediate Similarity NPD6373 Approved
0.7282 Intermediate Similarity NPD6372 Approved
0.7273 Intermediate Similarity NPD7509 Discontinued
0.7273 Intermediate Similarity NPD7514 Phase 3
0.7255 Intermediate Similarity NPD5701 Approved
0.7245 Intermediate Similarity NPD5696 Approved
0.7241 Intermediate Similarity NPD7322 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD6695 Phase 3
0.7204 Intermediate Similarity NPD4518 Approved
0.7196 Intermediate Similarity NPD6868 Approved
0.7191 Intermediate Similarity NPD6902 Approved
0.7176 Intermediate Similarity NPD4687 Approved
0.7176 Intermediate Similarity NPD5733 Approved
0.717 Intermediate Similarity NPD4632 Approved
0.7159 Intermediate Similarity NPD6683 Phase 2
0.7143 Intermediate Similarity NPD7338 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4808 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD7902 Approved
0.7143 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4809 Clinical (unspecified phase)
0.7128 Intermediate Similarity NPD6673 Approved
0.7128 Intermediate Similarity NPD6904 Approved
0.7128 Intermediate Similarity NPD6080 Approved
0.7103 Intermediate Similarity NPD5167 Approved
0.7093 Intermediate Similarity NPD8264 Approved
0.7087 Intermediate Similarity NPD6412 Phase 2
0.7079 Intermediate Similarity NPD7332 Phase 2
0.7079 Intermediate Similarity NPD8259 Clinical (unspecified phase)
0.7065 Intermediate Similarity NPD6893 Approved
0.7064 Intermediate Similarity NPD6335 Approved
0.7053 Intermediate Similarity NPD4096 Approved
0.703 Intermediate Similarity NPD5091 Approved
0.7021 Intermediate Similarity NPD5208 Approved
0.7 Intermediate Similarity NPD4692 Approved
0.7 Intermediate Similarity NPD7100 Approved
0.7 Intermediate Similarity NPD7101 Approved
0.7 Intermediate Similarity NPD4139 Approved
0.6989 Remote Similarity NPD6098 Approved
0.6979 Remote Similarity NPD7637 Suspended
0.6972 Remote Similarity NPD6009 Approved
0.6972 Remote Similarity NPD6317 Approved
0.6947 Remote Similarity NPD7285 Clinical (unspecified phase)
0.6947 Remote Similarity NPD6051 Approved
0.6941 Remote Similarity NPD5276 Approved
0.6939 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6937 Remote Similarity NPD6054 Approved
0.6915 Remote Similarity NPD7524 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data